<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>unicorns Archives - Claims Journal</title>
	<atom:link href="https://www.claimsjournal.com/topics/unicorns/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.claimsjournal.com/topics/unicorns/</link>
	<description>Insurance news and resources for the claims industry</description>
	<lastBuildDate>Tue, 15 Nov 2016 14:57:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://www.claimsjournal.com/app/uploads/2015/12/cropped-claimsjournal-32x32.png</url>
	<title>unicorns Archives - Claims Journal</title>
	<link>https://www.claimsjournal.com/topics/unicorns/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>SEC Focus on Unicorn Start Ups Could Change Private Company D&#038;O Insurance</title>
		<link>https://www.claimsjournal.com/news/national/2016/11/14/274801.htm</link>
		
						<dc:creator><![CDATA[Denise Johnson]]></dc:creator>
						<pubDate>Mon, 14 Nov 2016 09:10:31 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[federal securities laws]]></category>
		<category><![CDATA[private company valuations]]></category>
		<category><![CDATA[SEC]]></category>
		<category><![CDATA[Theranos]]></category>
		<category><![CDATA[unicorns]]></category>
		<category><![CDATA[Wiley Rein]]></category>
		<guid isPermaLink="false">https://www.claimsjournal.com/?p=274801</guid>

							<description><![CDATA[Unicorn start-ups are facing increasing scrutiny by the U.S. Securities and Exchange Commission (SEC) for several reasons, including the potential for inflated valuations and misleading statements both of which pose a risk to investors, according to Kim Melvin, a partner &#8230;]]></description>
				
		
			</item>
	</channel>
</rss>
